Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/11/22/2784744/0/en/Alladapt-Immunotherapeutics-Receives-FDA-Fast-Track-Designation-for-ADP101-for-the-Treatment-of-Mono-and-Multi-Food-Allergies.html
https://www.globenewswire.com//news-release/2023/11/09/2777583/0/en/Alladapt-Immunotherapeutics-Presents-Phase-1-2-Harmony-Data-Demonstrating-Therapeutic-Potential-and-Safety-of-ADP101-for-the-Treatment-of-Food-Allergy-at-2023-ACAAI-Annual-Meeting.html
https://www.globenewswire.com/news-release/2023/06/13/2686998/0/en/Alladapt-Immunotherapeutics-Announces-Topline-Pediatric-Data-from-Phase-1-2-Harmony-Study-Evaluating-ADP101-for-the-Treatment-of-Patients-with-Mono-and-Multi-Food-Allergy-as-Presen.html
https://endpts.com/alladapt-touts-data-on-food-allergy-drug-as-it-preps-for-phiii/
https://www.globenewswire.com/news-release/2023/05/16/2669796/0/en/Alladapt-Announces-Presentations-at-European-Academy-of-Allergy-and-Clinical-Immunology-EAACI-Congress-2023.html
https://www.globenewswire.com/news-release/2023/05/01/2658168/0/en/Alladapt-Appoints-Louise-Peacock-as-Chief-Regulatory-Affairs-and-Quality-Officer.html
https://www.globenewswire.com//news-release/2023/01/04/2582750/0/en/Alladapt-to-Present-at-the-41st-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2022/08/31/2507478/0/en/Alladapt-to-Participate-in-Citi-s-17th-Annual-BioPharma-Conference.html
https://www.globenewswire.com/news-release/2022/08/30/2506557/0/en/Alladapt-Announces-Loan-Agreement-with-Hercules-Capital.html
https://www.globenewswire.com/news-release/2022/06/22/2466957/0/en/Alladapt-Announces-Completion-of-Oversubscribed-119-Million-Institutional-Financing.html